| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |